Loading clinical trials...

The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT02505945

The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease

This study compares mechanical sphincter augmentation (LINX Reflux Management System) to double-dose proton pump inhibitors (PPIs) for the management of reflux symptoms related to gastroesophageal ref...

Lead sponsor: Torax Medical Incorporated•21 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

"The Voice of Reflux" - Backflow of Gastric Juice Leads to Irritation of the Vocal Folds: Are There Typical Differences in the Voice?

NCT06495606 · GERD Gastroesophageal Reflux Disease, Laryngopharyngeal Reflux Disease

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 7, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment152

Start dateJun 2015

Last updatedJan 7, 2019

Condition

GERD Gastroesophageal Reflux Disease

Locations shown

University of South Alabama

Mobile, Alabama

Bapist Health

Heber Springs, Arkansas

University of Southern California

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 7, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions